Kristine Sobering, LSCSW, LCAC | |
650 Huebner Rd, Fort Riley, KS 66442 | |
(785) 239-7208 | |
Not Available |
Full Name | Kristine Sobering |
---|---|
Gender | Female |
Speciality | Social Worker |
Location | 650 Huebner Rd, Fort Riley, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225271919 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Kristine Sobering, LSCSW, LCAC 650 Huebner Rd, Fort Riley, KS 66442-4030 Ph: (785) 239-7000 | Kristine Sobering, LSCSW, LCAC 650 Huebner Rd, Fort Riley, KS 66442 Ph: (785) 239-7208 |
News Archive
Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing Toll-like receptor (TLR) and RNA therapeutics for patients with cancer and rare diseases, today announced that the company has commenced enrollment in a Phase 2 clinical trial of IMO-8400, an investigational TLR 7, 8 and 9 antagonist, in patients with dermatomyositis. Dermatomyositis is a rare and debilitating inflammatory muscle and skin disease associated with significant morbidity, decreased quality of life and an increased risk of premature death.
An intensive teaching session helps emergency department physicians to reliably interpret head computed tomography scans when a radiologist is not on duty, a study shows.
Recently, a team of researchers from the US performed a comprehensive recombination analysis across all medically relevant human coronaviruses, including 158,118 public seasonal hCoV, SARS-CoV-1, SARS-CoV-2, and MERS-CoV genome sequences with the help of the RDP4 software. They aimed at identifying the current and future risks of the emergence of recombinants of SARS-CoV-2
A study comparing the efficacy and tolerability of two popular osteoporosis drugs, denosumab and zoledronic acid, found that denosumab had a significantly greater effect on increasing spine bone mineral density and zoledronic acid caused more flulike symptoms.
› Verified 6 days ago